Amgen Gross Profit 2006-2019 | AMGN

Amgen annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Amgen gross profit for the quarter ending December 31, 2019 was $4.944B, a 3.7% decline year-over-year.
  • Amgen gross profit for the twelve months ending December 31, 2019 was $19.006B, a 3.26% decline year-over-year.
  • Amgen annual gross profit for 2019 was $19.006B, a 3.26% decline from 2018.
  • Amgen annual gross profit for 2018 was $19.646B, a 4.61% increase from 2017.
  • Amgen annual gross profit for 2017 was $18.78B, a 0.26% decline from 2016.
Amgen Annual Gross Profit
(Millions of US $)
2019 $19,006
2018 $19,646
2017 $18,780
2016 $18,829
2015 $17,435
2014 $15,641
2013 $15,330
2012 $14,066
2011 $12,874
2010 $12,833
2009 $12,551
2008 $12,707
2007 $12,223
2006 $12,173
2005 $10,348
Amgen Quarterly Gross Profit
(Millions of US $)
Q4 2019 $4,944
Q3 2019 $4,701
Q2 2019 $4,859
Q1 2019 $4,502
Q4 2018 $5,134
Q3 2018 $4,867
Q2 2018 $5,035
Q1 2018 $4,610
Q4 2017 $4,743
Q3 2017 $4,783
Q2 2017 $4,786
Q1 2017 $4,468
Q4 2016 $4,898
Q3 2016 $4,784
Q2 2016 $4,638
Q1 2016 $4,509
Q4 2015 $4,465
Q3 2015 $4,689
Q2 2015 $4,281
Q1 2015 $4,000
Q4 2014 $4,148
Q3 2014 $3,963
Q2 2014 $4,099
Q1 2014 $3,431
Q4 2013 $3,982
Q3 2013 $3,960
Q2 2013 $3,894
Q1 2013 $3,494
Q4 2012 $3,499
Q3 2012 $3,544
Q2 2012 $3,725
Q1 2012 $3,298
Q4 2011 $3,036
Q3 2011 $3,339
Q2 2011 $3,357
Q1 2011 $3,142
Q4 2010 $3,269
Q3 2010 $3,229
Q2 2010 $3,251
Q1 2010 $3,084
Q4 2009 $3,271
Q3 2009 $3,267
Q2 2009 $3,182
Q1 2009 $2,831
Q4 2008 $3,193
Q3 2008 $3,198
Q2 2008 $3,249
Q1 2008 $3,067
Q4 2007 $3,139
Q3 2007 $2,819
Q2 2007 $3,170
Q1 2007 $3,095
Q4 2006 $3,274
Q3 2006 $3,123
Q2 2006 $3,111
Q1 2006 $2,665
Q4 2005 $2,760
Q3 2005 $2,602
Q2 2005 $2,642
Q1 2005 $2,344
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $124.084B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
CSL (CSLLY) Australia $95.484B 0.00
Gilead Sciences (GILD) United States $88.687B 11.42
Vertex Pharmaceuticals (VRTX) United States $59.632B 54.12
Biogen (BIIB) United States $56.416B 9.63
Regeneron Pharmaceuticals (REGN) United States $48.666B 20.61
Illumina (ILMN) United States $39.683B 41.03
Alexion Pharmaceuticals (ALXN) United States $21.285B 9.90
Seattle Genetics (SGEN) United States $19.359B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.724B 0.00
Incyte (INCY) United States $16.761B 35.96
BioMarin Pharmaceutical (BMRN) United States $16.346B 0.00
Genmab (GNMSF) Denmark $14.867B 47.82
Alnylam Pharmaceuticals (ALNY) United States $13.430B 0.00
Galapagos (GLPG) Belgium $13.052B 33.63
Exact Sciences (EXAS) United States $12.804B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.564B 54.03
BeiGene (BGNE) Cayman Islands $9.685B 0.00
Sarepta Therapeutics (SRPT) United States $8.482B 0.00
Moderna (MRNA) United States $7.996B 0.00
QIAGEN (QGEN) Netherlands $7.888B 24.29
Bio-Techne Corp (TECH) United States $7.580B 51.87
BioNTech SE (BNTX) Germany $7.566B 0.00
Guardant Health (GH) United States $7.117B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.346B 16.13
ACADIA Pharmaceuticals (ACAD) United States $6.264B 0.00
Amarin (AMRN) Ireland $6.251B 0.00
Ascendis Pharma (ASND) Denmark $6.218B 0.00
Reata Pharmaceuticals (RETA) United States $5.939B 0.00
Exelixis (EXEL) United States $5.895B 19.02
ARGENX SE-ADR (ARGX) Netherlands $5.850B 0.00
Acceleron Pharma (XLRN) United States $4.681B 0.00
China Biologic Products (CBPO) China $4.566B 25.72
Repligen (RGEN) United States $4.423B 80.91
Bluebird Bio (BLUE) United States $4.044B 0.00
Adaptive Biotechnologies (ADPT) United States $3.730B 0.00
MorphoSys AG (MOR) Germany $3.611B 0.00
Mirati Therapeutics (MRTX) United States $3.338B 0.00
Zai Lab (ZLAB) China $3.214B 0.00
Blueprint Medicines (BPMC) United States $3.202B 0.00
Immunomedics (IMMU) United States $3.179B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.172B 0.00
Alkermes (ALKS) Ireland $3.145B 249.13
Genmab (GMAB) Denmark $3.130B 12.28
Emergent Biosolutions (EBS) United States $3.093B 21.63
NeoGenomics (NEO) United States $3.076B 163.67
Momenta Pharmaceuticals (MNTA) United States $3.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.036B 51.43
MyoKardia (MYOK) United States $2.974B 0.00
Halozyme Therapeutics (HALO) United States $2.875B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.772B 0.00
Amicus Therapeutics (FOLD) United States $2.500B 0.00
Arena Pharmaceuticals (ARNA) United States $2.395B 5.57
UniQure (QURE) Netherlands $2.378B 0.00
Insmed (INSM) United States $2.353B 0.00
Fate Therapeutics (FATE) United States $2.296B 0.00
RA PHARMCTL INC (RARX) United States $2.200B 0.00
Denali Therapeutics (DNLI) United States $2.120B 0.00
Principia Biopharma (PRNB) United States $2.089B 0.00
Epizyme (EPZM) United States $1.957B 0.00
Alector (ALEC) United States $1.888B 0.00
REGENXBIO (RGNX) United States $1.750B 0.00
Ligand Pharmaceuticals (LGND) United States $1.746B 50.99
Arvinas (ARVN) United States $1.620B 0.00
Akcea Therapeutics (AKCA) United States $1.606B 37.17
Zymeworks (ZYME) Canada $1.592B 0.00
Coherus BioSciences (CHRS) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.367B 0.00
Myriad Genetics (MYGN) United States $1.341B 23.67
Nabriva Therapeutics AG (NBRV) Ireland $1.333B 0.00
Intra-Cellular Therapies (ITCI) United States $1.276B 0.00
Editas Medicine (EDIT) United States $1.153B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.149B 0.00
Twist Bioscience (TWST) United States $1.124B 0.00
Revance Therapeutics (RVNC) United States $1.117B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Athenex (ATNX) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.941B 0.00
Cytokineticsorporated (CYTK) United States $0.870B 0.00
DBV Technologies S.A (DBVT) France $0.860B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.849B 0.00
Mesoblast (MESO) Australia $0.827B 0.00
Sangamo Therapeutics (SGMO) United States $0.788B 0.00
Heska (HSKA) United States $0.781B 0.00
Codexis (CDXS) United States $0.758B 0.00
Vericel (VCEL) United States $0.746B 111.27
Intrexon (PGEN) United States $0.706B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 11.90
Cellectis S.A (CLLS) France $0.694B 0.00
Arcus Biosciences (RCUS) United States $0.682B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.640B 0.00
Retrophin (RTRX) United States $0.621B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.612B 5.41
Anika Therapeutics (ANIK) United States $0.608B 20.78
UROGEN PHARMA (URGN) United States $0.599B 0.00
Cel-Sci (CVM) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.592B 0.00
GENFIT S.A (GNFT) France $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.579B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.523B 0.00
Bellus Health (BLU) Canada $0.513B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 11.39
Prothena (PRTA) Ireland $0.485B 0.00
NantKwest (NK) United States $0.481B 0.00
Compugen (CGEN) Israel $0.464B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.457B 0.00
Puma Biotechnology (PBYI) United States $0.441B 0.00
Clovis Oncology (CLVS) United States $0.438B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Mersana Therapeutics (MRSN) United States $0.430B 0.00
AnaptysBio (ANAB) United States $0.423B 0.00
Agenus (AGEN) United States $0.408B 0.00
Precision BioSciences (DTIL) United States $0.407B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Merus (MRUS) Netherlands $0.405B 0.00
Pfenex (PFNX) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
Inovio Pharmaceuticals (INO) United States $0.379B 0.00
Sorrento Therapeutics (SRNE) United States $0.378B 0.00
Avid Bioservices (CDMO) United States $0.377B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.370B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.322B 0.00
Gritstone Oncology (GRTS) United States $0.319B 0.00
Stemline Therapeutics (STML) United States $0.316B 0.00
Albireo Pharma (ALBO) United States $0.308B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.279B 0.00
MannKind (MNKD) United States $0.279B 0.00
Aduro Biotech (ADRO) United States $0.279B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.270B 0.00
Kamada (KMDA) Israel $0.268B 11.13
Syros Pharmaceuticals (SYRS) United States $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.262B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.235B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Protagonist Therapeutics (PTGX) United States $0.233B 0.00
IVERIC Bio (ISEE) United States $0.230B 0.00
Geron (GERN) United States $0.230B 0.00
Kala Pharmaceuticals (KALA) United States $0.225B 0.00
VBI Vaccines (VBIV) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
XOMA (XOMA) United States $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.210B 0.00
Alcobra (ARCT) United States $0.208B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Abeona Therapeutics (ABEO) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
ChromaDex (CDXC) United States $0.195B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.193B 9.92
Athersys (ATHX) United States $0.193B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.192B 0.00
Arbutus Biopharma (ABUS) Canada $0.186B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
Cerecor (CERC) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Five Prime Therapeutics (FPRX) United States $0.177B 0.00
Affimed (AFMD) Germany $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Exicure (XCUR) United States $0.173B 0.00
VolitionRX (VNRX) Singapore $0.172B 0.00
Fortress Biotech (FBIO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
Verastem (VSTM) United States $0.146B 0.00
Dyadic (DYAI) United States $0.145B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Aptinyx (APTX) United States $0.142B 0.00
Northwest Biotherapeutics (NWBO) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
ARAVIVE, INC (ARAV) United States $0.131B 0.00
Arsanis (XFOR) United States $0.130B 0.00
Palatin Technologies (PTN) United States $0.128B 3.48
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
OvaScience (MLND) United States $0.116B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.114B 0.00
Clearside Biomedical (CLSD) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.107B 0.00
Prima BioMed (IMMP) Australia $0.106B 0.00
Vaccinex (VCNX) United States $0.099B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Proteostasis Therapeutics (PTI) United States $0.093B 0.00
Checkpoint Therapeutics (CKPT) United States $0.091B 0.00
Applied Genetic Technologies (AGTC) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
SESEN BIO, INC (SESN) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.075B 0.00
Pluristem Therapeutics (PSTI) Israel $0.072B 0.00
Orgenesis (ORGS) United States $0.068B 4.40
ANIXA BIOSCIENCES INC (ANIX) United States $0.067B 0.00
Acorda Therapeutics (ACOR) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.061B 0.00
DiaMedica Therapeutics (DMAC) United States $0.060B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
NewLink Genetics (NLNK) United States $0.055B 0.00
Advaxis (ADXS) United States $0.053B 0.00
Protalix BioTherapeutics (PLX) Israel $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Curis (CRIS) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
TOCAGEN INC (TOCA) United States $0.042B 0.00
Organovo Holdings (ONVO) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Oncobiologics (OTLK) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
IBio (IBIO) United States $0.024B 0.00
VIVUS (VVUS) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00